Domaine d'activité
Recherche & Développement
Activité
Corporate
Localisation
Marcq-en-Barœul, France
Type de contrat
Permanent Contract

Contribuez à une mission passionnante
A quoi ressemblera votre quotidien ?

The “LESAFFRE Biofoundry” (LESAFFRE Bioengineering team) – Lille Metropole conjunction to a second Gene Editing Synthetic Biology hub in the USA and deliver to the Lesaffre’s Mission of “Working together to better nourish and protect the planet.” 

Our Approach: We build an international team of motivated, risk-taking scientists and engineers to merge biology, engineering, automation, informatics to improve organism engineering, screening and selection for a wide portfolio of fermentation applications.

Our Scope: We engineer, screen, select yeast and bacteria for industrial biotechnology applications including baking, brewing, bioethanol, flavors and fragrances, food and feed, nutraceuticals, pharmaceuticals. 

As our Scientist focus on Flow-Cytometry / Microfluidic, your main responsibilities will be :

  • Developing and operating automated Flow cytometry assays for selection of Yeasts and other microorganisms.
  • Developing and operating automated advanced droplet microfluidics assays for selection of Yeasts and other microorganisms.
  • Organizing and supporting the validation and QC’ing of automated biological screening protocols.
  • Training of team members to protocols, workflows, and best practices.
  • Working with automation engineers, assay development scientists, metabolic engineering scientists and data scientists to ensure the technical quality.
  • Identifying and leading improvements in group practices and protocols.

Ayez un impact personnel
Ce qui fait de vous le candidat idéal

Mandatory:

  • Engineer or MSc in biology, cell biology, biochemistry, bioengineering, chemistry, chemical engineering or equivalent.
  • Demonstrated ability to work on single cell characterization/analysis such as, flow cytometry, FACS sorting, droplet microfluidic.
  • Strong organizational skills.

Prefered:

  • Demonstrated ability to develop novel cell-based screening assays is a plus.
  • Expertise in current technology and applications in microfluidics is desirable; hands on experience, development and micro-fabrication of microfluidic devices is a plus. 
  • Data and statistics background; ability to script simple data analysis in one the following, Matlab/Octave, Python or R is a plus.
  • PhD or 2-year industry research experience in biotechnology, assay development, or high/ultra-high throughput screening is a plus.
  • Familiar with diverse micro-organisms is a plus.
  • Knowledge of LIMS environments (e.g. Benchling) as well as statistical software packages (MiniTab, SPSS, etc.) is a plus.
  • Automation of data analysis of FACS and/or cytometry is a plus.

Grandissez au sein d’un réseau mondial
Ce que nous vous apportons

What Lesaffre can offer you : 

  • Join a family business rich in a long history with human-oriented values with a mission: To Nourish and Protect our Planet, 
  • Evolve in an enriching work environment and a multicultural context 
  • You will experience intellectual challenges within a multi-expertise network.

At Lesaffre, diversity is a strength that enriches our culture and our teams. We are committed to offering you a work environment where you can thrive, regardless of your background, gender, age or abilities. We encourage all applications, as we believe that diverse perspectives strengthen our ability to innovate and meet the challenges of tomorrow.

Relevons ensemble les défis de demain

As a global key player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for Baking, Food taste & pleasure, Health care and Biotechnology.

Family group born in northern France in 1853, now a multi-national and a multicultural company, Lesaffre is committed to working with confidence to better nourish and protect the planet.
In close collaboration with its clients and partners, Lesaffre employs 11 000 people in more than 50 countries.

Lesaffre achieves a turnover of 3 billion euros.